MedPath

Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant

Not Applicable
Completed
Conditions
Endoscopy
Interventions
Other: Carbon Dioxide
Other: Air
Registration Number
NCT04541667
Lead Sponsor
University of Nebraska
Brief Summary

During the course of an endoscopic procedure, air has historically been used to inflate the lumen to provide adequate visualization and allow for the endoscope to advance as necessary. In many adult centers, carbon dioxide is used for insufflation for all procedures. Many pediatric centers have started using carbon dioxide for insufflation during endoscopy based on the adult studies. Few pediatric studies have been done. This study is designed to test whether carbon dioxide is associated with any negative, post-procedural, outcomes in pediatric patients.

Detailed Description

Luminal inflation is essential for adequate visualization and endoscope advancement during endoscopy. Although air has previously been the standard gas used, CO2 is increasing preferred in adult endoscopy centers, due to reports of decreased post-procedural abdominal discomfort compared to air. Few published studies in children demonstrated decreased abdominal discomfort with use of CO2, but safety concerns for its use in pediatric endoscopy remain.

This is a Double-blinded, prospective, randomized study of all pediatric patients undergoing procedures involving upper endoscopy in the Childrens Hospital \& Medical Center. Randomization will be for patients undergoing upper endoscopy related procedures. Patients will be randomized 1:1 for air or CO2. Vital signs will be recorded before the procedure, throughout the procedure and after the procedure until fully awake. While in the procedure room, end-tidal CO2 level will be continuously recorded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Children 6 months to 19 years old and
  • Undergoing upper endoscopy at Children's Hospital & Medical Center in Omaha, NE and
  • Parents or legal guardians consent to the study
Exclusion Criteria
  • Patients and legal guardians who decline participation in the study
  • Patients with chronic respiratory disease (defined as severe asthma, bronchopulmonary dysplasia and cystic fibrosis-related pulmonary disease)
  • Patients with cyanotic heart disease
  • Patients with an ASA status of ≥ 3.
  • Patients who are wards of the state or in foster care
  • Prisoners
  • Patients undergoing colonoscopy only procedures or procedures not related to upper endoscopy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Carbon Dioxide for luminal inflationCarbon DioxidePatients randomized into this arm will have luminal inflation using carbon dioxide.
Air for luminal inflationAirPatients randomized into this arm will have luminal inflation using air.
Primary Outcome Measures
NameTimeMethod
Number of Procedures With Elevated End-tidal CO2 LevelsMeasured from time of procedure start to time of procedure conclusion this lasts usually from 1-2.5 hours.

Compare the peak end-tidal CO2 levels (\>/= 60 mmHg) observed during endoscopy in children managed with endotracheal intubation or laryngeal mask airway using CO2 versus air

Secondary Outcome Measures
NameTimeMethod
Number of Participants Reporting Abdominal PainThis will be assessed before and after the procedure

Pain rating scales using FLACC and VAS will be used to assess self reported pain before and after the procedure

Trial Locations

Locations (1)

Children's Hospital & Medical Center

🇺🇸

Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath